Professor Antoni Torres is considered a physician of reference both nationally and internationally in lung infections, including pneumonia, chronic obstructive pulmonary disease (COPD), bronchiectasis, immunocompromised patients, weaning, non-invasive ventilation (NIV), and acute respiratory distress syndrome (ARDS-ALI). He leads the research group on Management and prevention of infectious, interstitial and tumoral lung diseases of the August Pi i Sunyer Institute of Biomedical Research (IDIBAPS), from where he facilitates translational research studies.
He has taken part in many competitive research projects as principal researcher of the Health Care Research Fund (FIS). His research receives support from many public bodies, including the following: Carlos III Health Institute (ISCII), CibeRes, IDIBAPS, and the European Union. He is currently involved in more than 30 national, European and other international projects. He coordinates a CIBER group on respiratory diseases (CibeRes) and takes part in the European projects, GRACE, MOSAR (WP3, WP4) and Theraedge.
In his presentation ‘Severe Nosocomial Pneumonia and the New Aspects after Guidelines’, Professor Torres will discuss a new classification of nosocomial pneumonia, discus MDR/XDR microorganisms, and make recommendations for MDR Bacteria Management.